Associated Papers
A critical re-analysis of cases of post-transplantation recurrence in genetic nephrotic syndrome.
Mason AE et al.
Pediatric Nephrology (berlin, Germany), 2021
The amino acid mutations of the podocin in proteinuria: a meta-analysis.
Lu L et al.
Renal Failure, 2015
Mutations in NPHS2 (podocin) in Mexican children with nephrotic syndrome who respond to standard steroid treatment.
Carrasco-Miranda JS et al.
Genetics and Molecular Research : Gmr, 2013
Clinical features and mutational survey of NPHS2 (podocin) in Japanese children with focal segmental glomerulosclerosis who underwent renal transplantation.
Furue T et al.
Pediatric Transplantation, 2008
Podocin-related mechanisms in posttransplant [corrected] recurrence of focal segmental glomerulosclerosis [corrected].
Caridi G et al.
Transplantation Proceedings, 2006
New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis.
Vincenti F et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005
NPHS2 (Podocin) mutations in nephrotic syndrome. Clinical spectrum and fine mechanisms.
Caridi G et al.
Pediatric Research, 2005
Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.
Ruf RG et al.
Journal of the American Society of Nephrology : Jasn, 2004
Podocin mutations in sporadic focal-segmental glomerulosclerosis occurring in adulthood.
Caridi G et al.
Kidney International, 2003
Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin.
Bertelli R et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation, 2003
Select a paper to view details